Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Knoedler · SciRah

Researcher profile · Semantic Scholar

M. Knoedler

Share profile

M. Knoedler — researcher profile on SciRah

h-index: 9
Works: 27
Citations: 306

Most-cited papers

Sunitinib Treatment for Patients with Advanced Clear-Cell Renal-Cell Carcinoma after Progression on Sorafenib
K. Zimmermann, A. Schmittel, U. Steiner, A. Asemissen +4 more
2009Oncology86 citations
Semantic Scholar
CMV‐specific central memory T cells reside in bone marrow
A. Letsch, M. Knoedler, Il-Kang Na, F. Kern +6 more
2007European Journal of Immunology48 citations Open access
Semantic Scholar
Phase II Study of Cetuximab in Combination with Docetaxel in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck after Platinum-Containing Therapy: A Multicenter Study of the Arbeitsgemeinschaft Internistische Onkologie
M. Knoedler, T. Gauler, V. Gruenwald, A. Matzdorff +9 more
2013Oncology43 citations Open access
Semantic Scholar
Validation of the ONKOTEV Risk Prediction Model for Venous Thromboembolism in Outpatients With Cancer
C. Cella, M. Knoedler, M. Hall, M. Arcopinto +12 more
2023JAMA Network Open23 citations Open access
Semantic Scholar
Cetuximab, fluorouracil and cisplatin with or without docetaxel for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CeFCiD): an open-label phase II randomised trial (AIO/IAG-KHT trial 1108).
K. Klinghammer, T. Gauler, A. Dietz, V. Grünwald +14 more
2019European Journal of Cancer23 citations
Semantic Scholar
Multicenter phase II study of cetuximab plus docetaxel in 84 patients with recurrent or metastatic, platinum-pretreated SCCHN.
M. Knoedler, T. Gauler, A. Matzdorff, O. Jordan +6 more
2009Journal of Clinical Oncology14 citations
Semantic Scholar
Impact of indication-shift of primary and adjuvant chemo radiation in advanced laryngeal and hypopharyngeal squamous cell carcinoma
Andreas Boehm, F. Lindner, G. Wichmann, U. Bauer +7 more
2015European Archives of Oto-Rhino-Laryngology10 citations
Semantic Scholar
Phase II trial to evaluate efficacy and toxicity of cetuximab plus docetaxel in platinum pretreated patients with recurrent and/or metastatic head and neck cancer
M. Knoedler, T. Gauler, A. Matzdorff, A. Dietz +7 more
200810 citations
Semantic Scholar
First-in-man dose escalation and pharmacokinetic study of CAP7.1, a novel prodrug of etoposide, in adults with refractory solid tumours.
U. Keilholz, L. Rohde, P. Mehlitz, M. Knoedler +8 more
2017European Journal of Cancer9 citations
Semantic Scholar
EORTC 1707 VESTIGE: Adjuvant immunotherapy in patients with resected gastric cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1): An open-label randomized controlled phase II study.
E. Smyth, M. Knoedler, M. Nilsson, A. Wagner +5 more
20208 citations
Semantic Scholar
Effects of human papillomavirus (HPV) and other potential risk factors on survival in patients with oropharyngeal cancer.
M. Knoedler, A. Zakarneh, U. Zimmermann, K. Woelke +2 more
2011Journal of Clinical Oncology7 citations
Semantic Scholar
Intraperitoneal immunotherapy with the bispecific anti-EpCAM x anti-CD3 directed antibody catumaxomab for patients with peritoneal carcinomatosis from gastric cancer: Final results of a randomized phase II AIO trial.
F. Lordick, V. Kunzmann, J. Trojan, S. Daum +9 more
20186 citations
Semantic Scholar
Cetuximab (C), fluorouracil (F), and cisplatin (P) alone or with docetaxel (D) for recurrent/metastatic (RM) head and neck cancer (HNSCC): First analysis of AIO trial # 1108.
U. Keilholz, T. Gauler, A. Dietz, V. Gruenwald +13 more
20145 citations
Semantic Scholar
Interference of amphiregulin and EGFRvIII expression with outcome of patients with squamous cell carcinoma of the head and neck (SCCHN) receiving cetuximab-docetaxel treatment.
I. Tinhofer, K. Klinghammer, W. Weichert, M. Knoedler +4 more
2011Journal of Clinical Oncology5 citations
Semantic Scholar
987OCETUXIMAB (C), FLUOROURACIL (F) AND CISPLATIN (P) ALONE OR WITH DOCETAXEL (D) FOR RECURRENT/METASTATIC (RM) HEAD AND NECK CANCER (HNSCC). FINAL ANALYSIS OF AIO TRIAL # 1108 - CEFCID.
M. Knoedler, T. Gauler, A. Dietz, Viktor Grünwald +13 more
2014Annals of Oncology4 citations Open access
Semantic Scholar
Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel within the CEFCID Trial
U. Goerling, T. Gauler, A. Dietz, V. Grünwald +13 more
2021Oncology Research and Treatment2 citations Open access
Semantic Scholar
614 First-in-man Dose Escalation and Pharmacokinetic Study of CAP7.1, a Novel Etoposide Prodrug in Adults with Heavily Pretreated Solid Tumors
U. Keilholz, M. Knoedler, A. Schmittel, V. Kümmerlen +6 more
20122 citations
Semantic Scholar
[Head and Neck Cancer in Pregnancy - Recommendations for Diagnosis and Therapy With Case Report].
C. Mozet, T. Kuhnt, B. Sattler, J. Remmele +5 more
2016Laryngo-Rhino-Otologie1 citations
Semantic Scholar
Cetuximab, fluorouracil (5-FU), cisplatin, and docetaxel as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): Interim results of a randomized phase II clinical trial (CeFCiD).
M. Knoedler, A. Dietz, T. Gauler, V. Gruenwald +9 more
20131 citations
Semantic Scholar
HPV and Other Risk Factors: Oropharyngeal Tumor Survival
O. Kaschke, A. Zakarneh, M. Knoedler, U. Zimmermann +2 more
20111 citations Open access
Semantic Scholar
Tumor stage at diagnosis as an indicator of cancer screening efficacy in diverse populations.
U. Keilholz, J. Blohmer, M. de Wit, C. Grohe +2 more
2025Journal of Clinical Oncology0 citations Open access
Semantic Scholar
144P Artificial intelligence supported treatment decisions for precision oncology
D. Rieke, X. Wang, M. Schmidt, D. Soll +7 more
2023Annals of Oncology0 citations Open access
Semantic Scholar
1670MO Validation of a new risk-assessment model for prediction of venous thromboembolism in cancer outpatients: The ONKOTEV score
C. Cella, M. Knoedler, M. Hall, S. Pellicori +5 more
2021Annals of Oncology0 citations Open access
Semantic Scholar
Risk factors for cancer-related venous thromboembolism in ambulatory patients.
C. Cella, M. Arcopinto, F. Lordick, C. Carlomagno +12 more
20140 citations
Semantic Scholar
Pretreatment characteristics and early indicators of long-term efficacy of cetuximab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck (rmSCCHN).
U. Keilholz, M. Knoedler, Ines Redlich, T. Gauler
20130 citations
Semantic Scholar
Correlation between PI3K/PTEN/AKT/mTOR pathway genetic variations and clinical outcome in patients with squamous cell carcinoma of the head and neck receiving cetuximab-docetaxel treatment.
A. Fusi, Katharina Pfisterer, K. Klinghammer, M. Knoedler +2 more
20120 citations
Semantic Scholar
EORTC 1707 VESTIGE: Adjuvant immunotherapy in patients with resected gastric cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1)—An open-label randomized controlled phase II study.
E. Smyth, E. Peeters, M. Knoedler, A. Giraut +6 more
Journal of Clinical Oncology0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

U. Keilholz×10
Invite
U. Keilholz — researcher profile on SciRah
M. Schroeder×6
Invite
M. Schroeder — researcher profile on SciRah
F. Lordick×6
Invite
F. Lordick — researcher profile on SciRah
K. Klinghammer×6
Invite
K. Klinghammer — researcher profile on SciRah

×6

Invite

T. Gauler — researcher profile on SciRah

V. Gruenwald×5

Invite

V. Gruenwald — researcher profile on SciRah

Invite

A. Dietz — researcher profile on SciRah

Ulrich Keilholz×5

Invite

Ulrich Keilholz — researcher profile on SciRah

Invite

S. Knipping — researcher profile on SciRah

O. Guntinas-Lichius×5

Invite

O. Guntinas-Lichius — researcher profile on SciRah

Invite

B. Haxel — researcher profile on SciRah

Invite

T. Gauler — researcher profile on SciRah